Celltrion holdings Nasdaq
Scope
Date
~
-
Bio & Pharma
Celltrion BioSolutions launched to venture into CDMO
Celltrion Inc. on Tuesday launched its contract development and manufacturing organization unit Celltrion BioSolutions Co. in its foray into the CDM...
Dec 17, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s 4 new biosimilars win EU approval recommendation
Celltrion Inc. is one step closer to commercializing its four new biosimilars in Europe after a committee of the European Medicines Agency (EMA) rec...
Dec 16, 2024 (Gmt+09:00)
-
Economy
S.Korea to hold IR session to unveil market-boosting steps
South Korea's government will host an overseas investor relations session to explain the country’s economic conditions and unveil market-boost...
Dec 16, 2024 (Gmt+09:00)
-
Foreign exchange
Korean won seen rebounding after Yoon’s impeachment
The South Korean won is expected to stage a rebound from its two-year low against the US dollar and hold steady in 2025 after the impeachment of Sou...
Dec 15, 2024 (Gmt+09:00)
-
Markets
Celltrion to allot cash, stock dividend at once
South Korea’s biosimilar maker Celltrion Inc. on Friday announced a plan to allot cash and stock dividends simultaneously. The company wi...
Dec 13, 2024 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma acquires ABO Holding for $96 mn
South Korea’s GC Biopharma Corp. said on Thursday it acquired the US-based medical-grade source blood plasma company ABO Holding Inc. The...
Dec 12, 2024 (Gmt+09:00)
-
Corporate restructuring
NPS steps back from Doosan Robotics' Bobcat merger
The National Pension Service (NPS) appears to be stalling on a vote for Doosan Robotics Inc.'s merger with Doosan Bobcat Inc., with major proxy advi...
Dec 09, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets approval of Omlyclo in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...
Dec 09, 2024 (Gmt+09:00)
-
Shareholder value
Celltrion to retire $400 mn treasury stock in January
South Korea’s biosimilar maker Celltrion Inc. on Wednesday announced a plan to retire about a quarter of its treasury stock worth 563 billion ...
Dec 04, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to break ground on CDMO plant in 2025: Chairman Seo
South Korea’s leading biosimilar developer Celltrion Inc. will break ground on its first contract development and manufacturing organization (...
Nov 28, 2024 (Gmt+09:00)
-
Venture capital
S.Korean gov't eases restrictions on Korean investment in overseas startups
The companies founded by South Korean nationals abroad will be recognized as domestic companies if they contribute to the Korean economy, making it ...
Nov 25, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Remsima on course to become Korea’s 1st blockbuster drug
Celltrion Inc.'s Remsima, the world’s first biosimilar monoclonal antibody, is on track to exceed 1 trillion won ($713 million) in sales this ...
Nov 25, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to acquire additional $72 mn in treasury shares
South Korea's Celltrion Inc. announced on Thursday that it decided to repurchase additional treasury shares worth 100 billion won ($71.6 million).Fr...
Nov 21, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion acquires Swiss pharmaceutical distributor iQone
South Korea's Celltrion Inc. said on Friday that it completed its acquisition of iQone Healthcare Switzerland, a Swiss pharmaceutical distributor, t...
Nov 15, 2024 (Gmt+09:00)
-
Banking & Finance
SFH, where foreign firms build networks in Korea
It can be daunting to do business in a new city in a distant country. But foreign companies seeking to open businesses in South Korea’s capita...
Nov 13, 2024 (Gmt+09:00)
-
Korean Investors
Mirae Asset’s TIGER Nasdaq 100 ETF crosses $2.8 bn in net assets
South Korea's Mirae Asset Global Investments said on Tuesday that that its TIGER Nasdaq 100 ETF has become the second US-focused ETF listed in South...
Nov 13, 2024 (Gmt+09:00)
-
Korean Investors
S.Korean investors' US stock holdings surpass $100 bn
The US stock holdings of South Korean individual investors surpassed $100 billion for the first time, driven by a sustained rally in the US markets ...
Nov 11, 2024 (Gmt+09:00)
-
Automobiles
Kia holds exhibition reflecting on 80-year-history
Kia Corp., South Korea’s second-largest automaker, said on Thursday it opened a heritage exhibition "From Moments to Movement," showcasing its...
Nov 07, 2024 (Gmt+09:00)
-
Korean stock market
MSCI Korea Index adds Hyundai Rotem
MSCI announced on Wednesday that South Korea's Hyundai Rotem Co. will be added to the Morgan Stanley Capital International (MSCI) Korea Index. ...
Nov 07, 2024 (Gmt+09:00)
-
Shareholder activism
Dalton Investments raises stake in cosmetics ODM Kolmar
Dalton Investments Inc., a US-based activist fund, has secured a 5.02% stake in South Korea’s Kolmar Holdings Co., stoking speculation the wor...
Nov 06, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion releases Steqeyma in Europe
South Korea's Celltrion Inc. said on Monday it released Steqeyma (ustekinumab) in Europe, the biosimilar of autoimmune disease treatment Stelara.T...
Nov 05, 2024 (Gmt+09:00)
-
Energy
Czech anti-trust body puts signing of nuclear power deal on hold
The Czech anti-trust body put a temporary block on the conclusion of a contract with Korea Hydro & Nuclear Power Co. (KHNP) for the construction...
Oct 31, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Zymfentra gets 90% distribution channel in US
South Korean biosimilar maker Celltrion Inc. said on Monday its subcutaneous injection formulation for autoimmune diseases, Zymfentra (infliximab), ...
Oct 30, 2024 (Gmt+09:00)
-
IPOs
South Korea’s Viva Republica drops Korean IPO plan, seeks US debut
Viva Republica Inc., a leading South Korean fintech unicorn and operator of mobile financial super app Toss, has dropped its plan to go public in th...
Oct 29, 2024 (Gmt+09:00)
-
Korean food
S.Korea's Daesang holds kimchi contest in US
South Korea's Daesang Corp. said on Monday it hosted the "Jongga Kimchi Blast" event in the US to promote kimchi and elevate Korean food culture.&...
Oct 29, 2024 (Gmt+09:00)
-
Batteries
POSCO completes lithium hydroxide plant in Argentina
POSCO Holdings Inc. said on Sunday it completed a lithium hydroxide plant in Argentina, boosting its capacity to produce electric vehicle (EV) batte...
Oct 28, 2024 (Gmt+09:00)
-
Culture & Trends
Seoul to light up Myeong-dong with LEDs like Times Square
Seoul will light up Myeong-dong, a bustling area with office workers and shoppers in the heart of the city, with 16 large outdoor digital billboards...
Oct 23, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to establish CDMO subsidiary
Celltrion Inc., South Korea’s largest biosimilar maker, said on Friday it plans to establish a contract development and manufacturing organiza...
Oct 18, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
MBK wins enough stake in tender offer to control Korea Zinc
North Asia-focused private equity firm MBK Partners Ltd. has secured a large enough stake in Korea Zinc Inc. through a tender offer to take control ...
Oct 14, 2024 (Gmt+09:00)
-
Corporate strategy
Lotte Shopping to set up Singapore holding firm, eyes its IPO
Lotte Shopping Co., South Korea’s leading retail company, will transform its special purpose company (SPC) in Singapore into a holding firm to...
Oct 11, 2024 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand